Aldeyra Therapeutics Schedules Webcast and Conference Call to Provide First-Quarter 2020 Financial Results and Corporate Update
30 April 2020 - 10:00PM
Business Wire
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a
clinical-stage biotechnology company focused on the development of
novel therapies with the potential to improve the lives of patients
with immune-mediated diseases, will host a conference call at 8:00
a.m. ET on Thursday, May 7, 2020, to discuss financial results for
the quarter ended March 31, 2020, and provide a corporate
update.
The dial-in numbers are (866) 211-4098 for domestic callers and
(647) 689-6613 for international callers. The Conference ID number
is 6982314. A live webcast of the conference call will also be
available on the investor relations page of the company’s corporate
website at https://ir.aldeyra.com.
After the live webcast, the event will remain archived on the
Aldeyra Therapeutics website for 90 days.
About Aldeyra Therapeutics Aldeyra Therapeutics is a
clinical-stage biotechnology company focused on the development of
novel therapies with the potential to improve the lives of patients
with immune-mediated diseases. Two of the company’s lead compounds,
reproxalap and ADX-629, target reactive aldehyde species (RASP),
which are elevated in ocular and systemic inflammatory disease,
leading to activation of a broad array of inflammatory factors,
including NF-κB, inflammasomes, and Scavenger Receptor A.
Reproxalap is being evaluated in Phase 3 clinical trials in
patients with dry eye disease and allergic conjunctivitis. The
company’s clinical pipeline also includes ADX-2191, a dihydrofolate
reductase inhibitor in Phase 3 testing for proliferative
vitreoretinopathy.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200430005178/en/
Corporate Contact: David McMullin Aldeyra Therapeutics,
Inc. Tel: 781-761-4904 ext. 218 dmcmullin@aldeyra.com
Investor & Media Contact: Scott Solomon Sharon
Merrill Associates, Inc. Tel: 617-542-5300
ALDX@investorrelations.com
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From Apr 2024 to May 2024
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From May 2023 to May 2024